ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 393

$467K Total Retail Price of All Prescriptions

Rank: 74 out of 393

830 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 830 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 830 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,165 999 1 2
SIMVASTATIN 1,083 990 2 1
OMEPRAZOLE 646 542 3 6
AMLODIPINE BESYLATE 595 516 4 4
LEVOTHYROXINE SODIUM 553 433 5 3
HYDROCODONE-ACETAMINOPHEN 455 315 S3 6 5
LOVASTATIN 420 403 7 14
ALENDRONATE SODIUM 409 396 8 16
GLIPIZIDE 407 343 9 32
METFORMIN HCL 385 324 10 7
ATENOLOL 325 259 11 13
PRAVASTATIN SODIUM 313 249 12 18
METOPROLOL TARTRATE 254 229 13 9
WARFARIN SODIUM 247 211 14 17
SERTRALINE HCL 241 203 15 28
ATORVASTATIN CALCIUM 239 204 16 19
BACLOFEN 226 175 17 79
PIROXICAM 212 180 18 180
GABAPENTIN 173 126 19 15
VENTOLIN HFA 170 136 20 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 162 20 24
FUROSEMIDE 157 127 22 8
EVISTA 156 144 23 98
METOPROLOL SUCCINATE 144 139 24 22
GEMFIBROZIL 138 93 25 62
CLOPIDOGREL 134 112 26 33
PLAVIX 127 106 27 51
POTASSIUM CHLORIDE 125 125 28 20
FLUTICASONE PROPIONATE 113 112 29 27
DILTIAZEM 24HR ER 108 97 30 129
DONEPEZIL HCL 106 106 31 34
HYDROCHLOROTHIAZIDE 103 80 32 10
DILTIAZEM ER 103 91 32 107
TRAZODONE HCL 102 91 34 47
RANITIDINE HCL 101 93 35 29
NIFEDIPINE ER 100 89 36 91
CARVEDILOL 95 79 37 21
TAMSULOSIN HCL 90 89 38 25
LANTUS SOLOSTAR 86 44 39 74
SPIRIVA 85 69 40 41
GLYBURIDE 82 76 R 41 46
TERAZOSIN HCL 80 78 42 38
ETODOLAC 78 75 43 165
ALLOPURINOL 77 77 44 26
FINASTERIDE 75 74 45 60
ISOSORBIDE MONONITRATE ER 74 60 46 67
OXYCODONE HCL-ACETAMINOPHEN 72 54 S2 47 54
CLONIDINE HCL 72 59 47 50
PAROXETINE HCL 71 58 49 61
TRIAMTERENE-HCTZ 65 56 50 49
BENAZEPRIL HCL 64 63 51 40
VERAPAMIL ER 63 60 52 86
LIPITOR 61 51 53 123
TRAMADOL HCL 61 41 53 30
ZOLPIDEM TARTRATE 61 43 53 11
LOSARTAN POTASSIUM 60 54 56 12
QVAR 58 41 57 101
PEN NEEDLE 56 35 58 81
ACTOS 55 50 59 78
CARTIA XT 55 54 59 223
GLIPIZIDE ER 55 55 59 76
FLUOXETINE HCL 50 42 62 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.